{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:14:05Z","timestamp":1792732445433,"version":"4.5.0"},"publisher-location":"New York, NY","reference-count":23,"publisher":"Springer US","isbn-type":[{"value":"9781071607947","type":"print"},{"value":"9781071607954","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-1-0716-0795-4_18","type":"book-chapter","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T16:11:58Z","timestamp":1600704718000},"page":"357-366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Surface Modification of Adenovirus Vector to Improve Immunogenicity and Tropism"],"prefix":"10.1007","author":[{"given":"Yasmine","family":"Gabal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,22]]},"reference":[{"issue":"5","key":"18_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3015","volume":"20","author":"SL Ginn","year":"2018","unstructured":"Ginn SL et al (2018) Gene therapy clinical trials worldwide to 2017: an update. J Gene Med 20(5):e3015","journal-title":"J Gene Med"},{"issue":"4","key":"18_CR2","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","volume":"10","author":"N Tatsis","year":"2004","unstructured":"Tatsis N, Ertl HC (2004) Adenoviruses as vaccine vectors. Mol Ther 10(4):616\u2013629","journal-title":"Mol Ther"},{"issue":"7","key":"18_CR3","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1128\/JVI.62.7.2321-2328.1988","volume":"62","author":"C Wohlfart","year":"1988","unstructured":"Wohlfart C (1988) Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms. J Virol 62(7):2321\u20132328","journal-title":"J Virol"},{"issue":"3","key":"18_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/gt.2009.148","volume":"17","author":"S Nayak","year":"2010","unstructured":"Nayak S, Herzog RW (2010) Progress and prospects: immune responses to viral vectors. Gene Ther 17(3):295","journal-title":"Gene Ther"},{"issue":"1","key":"18_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1089\/hum.1997.8.1-37","volume":"8","author":"S Worgall","year":"1997","unstructured":"Worgall S et al (1997) Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum Gene Ther 8(1):37\u201344","journal-title":"Hum Gene Ther"},{"issue":"2","key":"18_CR6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.virusres.2009.02.010","volume":"143","author":"A Sharma","year":"2009","unstructured":"Sharma A et al (2009) Adenovirus receptors and their implications in gene delivery. Virus Res 143(2):184\u2013194","journal-title":"Virus Res"},{"issue":"5304","key":"18_CR7","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","volume":"275","author":"JM Bergelson","year":"1997","unstructured":"Bergelson JM et al (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275(5304):1320\u20131323","journal-title":"Science"},{"issue":"24","key":"18_CR8","doi-asserted-by":"publisher","first-page":"12775","DOI":"10.1128\/JVI.76.24.12775-12782.2002","volume":"76","author":"H Wu","year":"2002","unstructured":"Wu H et al (2002) Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon. J Virol 76(24):12775\u201312782","journal-title":"J Virol"},{"issue":"5","key":"18_CR9","doi-asserted-by":"publisher","first-page":"511","DOI":"10.4161\/cbt.2.5.440","volume":"2","author":"AL Volk","year":"2003","unstructured":"Volk AL et al (2003) Enhanced adenovirus infection of melanoma cells by fiber-modification: incorporation of RGD peptide or Ad5\/3 chimerism. Cancer Biol Ther 2(5):511\u2013515","journal-title":"Cancer Biol Ther"},{"issue":"5","key":"18_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/sj.gt.3301389","volume":"8","author":"K Fisher","year":"2001","unstructured":"Fisher K et al (2001) Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies. Gene Ther 8(5):341","journal-title":"Gene Ther"},{"key":"18_CR11","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1089\/10430349950018021","volume":"10","author":"C O\u2019Riordan","year":"1999","unstructured":"O\u2019Riordan C, Lachapelle A, Delgado C, Parkes V (1999) Wadsworth SC Smith AE Francis GE PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo. Hum Gene Ther 10:1349\u20131358","journal-title":"Hum Gene Ther"},{"issue":"8","key":"18_CR12","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/sj.gt.3300471","volume":"4","author":"A Baker","year":"1997","unstructured":"Baker A et al (1997) Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene delivery. Gene Ther 4(8):773","journal-title":"Gene Ther"},{"issue":"23","key":"18_CR13","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1016\/S0142-9612(02)00203-X","volume":"23","author":"Y Kawamata","year":"2002","unstructured":"Kawamata Y et al (2002) Receptor-independent augmentation of adenovirus-mediated gene transfer with chitosan in vitro. Biomaterials 23(23):4573\u20134579","journal-title":"Biomaterials"},{"issue":"10","key":"18_CR14","doi-asserted-by":"publisher","first-page":"6479","DOI":"10.1074\/jbc.272.10.6479","volume":"272","author":"A Fasbender","year":"1997","unstructured":"Fasbender A et al (1997) Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo. J Biol Chem 272(10):6479\u20136489","journal-title":"J Biol Chem"},{"issue":"10","key":"18_CR15","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.1128\/JVI.75.10.4792-4801.2001","volume":"75","author":"MA Croyle","year":"2001","unstructured":"Croyle MA et al (2001) \u201cStealth\u201d adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung. J Virol 75(10):4792\u20134801","journal-title":"J Virol"},{"issue":"2","key":"18_CR16","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3390\/v2020468","volume":"2","author":"P Wonganan","year":"2010","unstructured":"Wonganan P, Croyle MA (2010) PEGylated adenoviruses: from mice to monkeys. Viruses 2(2):468\u2013502","journal-title":"Viruses"},{"issue":"4","key":"18_CR17","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/ijc.20129","volume":"110","author":"A Kanerva","year":"2004","unstructured":"Kanerva A, Hemminki A (2004) Modified adenoviruses for cancer gene therapy. Int J Cancer 110(4):475\u2013480","journal-title":"Int J Cancer"},{"issue":"12","key":"18_CR18","doi-asserted-by":"publisher","first-page":"9706","DOI":"10.1128\/JVI.72.12.9706-9713.1998","volume":"72","author":"I Dmitriev","year":"1998","unstructured":"Dmitriev I et al (1998) An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol 72(12):9706\u20139713","journal-title":"J Virol"},{"key":"18_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.biopha.2015.02.015","volume":"71","author":"AS Nigatu","year":"2015","unstructured":"Nigatu AS et al (2015) Effects of cell-penetrating peptides on transduction efficiency of PEGylated adenovirus. Biomed Pharmacother 71:153\u2013160","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"18_CR20","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1002\/jps.23556","volume":"102","author":"AS Nigatu","year":"2013","unstructured":"Nigatu AS et al (2013) Evaluation of cell-penetrating peptide\/adenovirus particles for transduction of CAR-negative cells. J Pharm Sci 102(6):1981\u20131993","journal-title":"J Pharm Sci"},{"issue":"1","key":"18_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jconrel.2007.06.010","volume":"122","author":"J-Q Gao","year":"2007","unstructured":"Gao J-Q et al (2007) Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration. J Control Release 122(1):102\u2013110","journal-title":"J Control Release"},{"issue":"12","key":"18_CR22","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1089\/10430340050111368","volume":"11","author":"MA Croyle","year":"2000","unstructured":"Croyle MA, Yu Q-C, Wilson JM (2000) Development of a rapid method for the PEGylation of adenoviruses with enhanced transduction and improved stability under harsh storage conditions. Hum Gene Ther 11(12):1713\u20131722","journal-title":"Hum Gene Ther"},{"issue":"1","key":"18_CR23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/0003-2697(86)90520-8","volume":"154","author":"SJ Stocks","year":"1986","unstructured":"Stocks SJ et al (1986) A fluorometric assay of the degree of modification of protein primary amines with polyethylene glycol. Anal Biochem 154(1):232\u2013234","journal-title":"Anal Biochem"}],"container-title":["Methods in Molecular Biology","Vaccine Delivery Technology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-0795-4_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T16:17:15Z","timestamp":1600705035000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-0716-0795-4_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,22]]},"ISBN":["9781071607947","9781071607954"],"references-count":23,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-0795-4_18","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,22]]},"assertion":[{"value":"22 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}